Cargando…
Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme
Upregulation of neprilysin (NEP) to reduce Aβ accumulation in the brain is a promising strategy for the prevention of Alzheimer’s disease (AD). This report describes the design and synthesis of a quenched fluorogenic peptide substrate qf-Aβ(12–16)AAC (with the sequence VHHQKAAC), which has a fluorop...
Autores principales: | Chen, Po-Ting, Chen, Chao-Long, Lin, Lilian Tsai-Wei, Lo, Chun-Hsien, Hu, Chaur-Jong, Chen, Rita P.-Y., Wang, Steven S.-S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838334/ https://www.ncbi.nlm.nih.gov/pubmed/27096746 http://dx.doi.org/10.1371/journal.pone.0153360 |
Ejemplares similares
-
Molecular Basis
for Omapatrilat and Sampatrilat Binding
to Neprilysin—Implications for Dual Inhibitor Design with Angiotensin-Converting
Enzyme
por: Sharma, Urvashi, et al.
Publicado: (2020) -
Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016) -
Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021) -
Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials
por: Bratsos, Sosipatros
Publicado: (2019) -
The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)